These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 36817416)
1. Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review. Chang K; Li Y; Qin Z; Zhang Z; Wang L; Yang Q; Geng J; Deng N; Chen S; Su B Front Immunol; 2023; 14():1074465. PubMed ID: 36817416 [TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review. Bonavia A; Groff A; Karamchandani K; Singbartl K Blood Purif; 2018; 46(4):337-349. PubMed ID: 30176653 [TBL] [Abstract][Full Text] [Related]
3. Hemoadsorption by CytoSorb in septic patients: a case series. Kogelmann K; Jarczak D; Scheller M; Drüner M Crit Care; 2017 Mar; 21(1):74. PubMed ID: 28343448 [TBL] [Abstract][Full Text] [Related]
4. Application of extracorporeal therapies in critically ill COVID-19 patients. Zhou Z; Kuang H; Ma Y; Zhang L J Zhejiang Univ Sci B; 2021 Sept 15; 22(9):701-717. PubMed ID: 34514751 [TBL] [Abstract][Full Text] [Related]
5. Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation. Ronco C; Bagshaw SM; Bellomo R; Clark WR; Husain-Syed F; Kellum JA; Ricci Z; Rimmelé T; Reis T; Ostermann M Blood Purif; 2021; 50(1):17-27. PubMed ID: 32454500 [TBL] [Abstract][Full Text] [Related]
6. Hemoadsorption for severe MIS-C in critically ill children, should we consider it as a therapeutic opportunity? Bottari G; Severini F; Markowich AH; Lorenzetti G; Ruiz Rodriguez JC; Ferrer R; Francalanci P; Ammirati A; Palma P; Cecchetti C Int J Artif Organs; 2022 Oct; 45(10):871-877. PubMed ID: 35822878 [TBL] [Abstract][Full Text] [Related]
7. Blood purification therapy in patients with severe COVID-19 requiring veno-venous ECMO therapy: A retrospective study. Akil A; Ziegeler S; Rehers S; Ernst EC; Fischer S Int J Artif Organs; 2022 Jul; 45(7):615-622. PubMed ID: 35695200 [TBL] [Abstract][Full Text] [Related]
8. Blood purification in sepsis and COVID-19: what´s new in cytokine and endotoxin hemoadsorption. Ruiz-Rodríguez JC; Plata-Menchaca EP; Chiscano-Camón L; Ruiz-Sanmartin A; Ferrer R J Anesth Analg Crit Care; 2022 Apr; 2(1):15. PubMed ID: 37386575 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series. Wunderlich-Sperl F; Kautzky S; Pickem C; Hörmann C Int J Artif Organs; 2021 Oct; 44(10):694-702. PubMed ID: 34256643 [TBL] [Abstract][Full Text] [Related]
10. Blood purification with CytoSorb in critically ill COVID-19 patients: A case series of 26 patients. Nassiri AA; Hakemi MS; Miri MM; Shahrami R; Koomleh AA; Sabaghian T Artif Organs; 2021 Nov; 45(11):1338-1347. PubMed ID: 34152629 [TBL] [Abstract][Full Text] [Related]
11. Hemoadsorption cartridge and coronavirus disease 2019 infections: A case report and brief literature review. Melegari G; Bertellini E; Melegari A; Trenti T; Malaguti S; Barbieri A Artif Organs; 2021 May; 45(5):E130-E135. PubMed ID: 33084021 [TBL] [Abstract][Full Text] [Related]
12. Effect of Continuous Renal Replacement Therapy with the oXiris Hemofilter on Critically Ill Patients: A Narrative Review. Li Y; Sun P; Chang K; Yang M; Deng N; Chen S; Su B J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431196 [TBL] [Abstract][Full Text] [Related]
13. Cytokine Hemoadsorption as Rescue Therapy for Critically Ill Patients With SARS-CoV-2 Pneumonia With Severe Respiratory Failure and Hypercytokinemia. Ruiz-Rodríguez JC; Chiscano-Camón L; Ruiz-Sanmartin A; Palmada C; Paola Plata-Menchaca E; Franco-Jarava C; Pérez-Carrasco M; Hernández-González M; Ferrer R Front Med (Lausanne); 2021; 8():779038. PubMed ID: 35083241 [No Abstract] [Full Text] [Related]
14. Blood purification in sepsis: a new paradigm. Peng Z; Singbartl K; Simon P; Rimmelé T; Bishop J; Clermont G; Kellum JA Contrib Nephrol; 2010; 165():322-328. PubMed ID: 20427984 [TBL] [Abstract][Full Text] [Related]
15. The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences. Ruiz-Rodríguez JC; Molnar Z; Deliargyris EN; Ferrer R Crit Care Res Pract; 2021; 2021():7769516. PubMed ID: 34336280 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19). Asgharpour M; Mehdinezhad H; Bayani M; Zavareh MSH; Hamidi SH; Akbari R; Ghadimi R; Bijani A; Mouodi S BMC Nephrol; 2020 Aug; 21(1):356. PubMed ID: 32819292 [TBL] [Abstract][Full Text] [Related]
17. Targeting circulating high mobility group box-1 and histones by extracorporeal blood purification as an immunomodulation strategy against critical illnesses. Li Y; Chen Y; Yang T; Chang K; Deng N; Zhao W; Su B Crit Care; 2023 Feb; 27(1):77. PubMed ID: 36855150 [TBL] [Abstract][Full Text] [Related]
18. Hemoadsorption in critically ill patients with or without COVID-19: A word of caution. Putzu A; Schorer R J Crit Care; 2021 Oct; 65():140-141. PubMed ID: 34148009 [No Abstract] [Full Text] [Related]